Molecular Imaging: Page 24

Imaging demonstrates how HIV scores 'direct hit' to heart muscle

By Kate Madden Yee

The human immunodeficiency virus (HIV) may have an impact on the heart not only via the development of coronary artery disease but also by a "direct hit to the heart muscle," a team of researchers from a top London facility has found.

September 15, 2022

GE, Lantheus highlight flurpiridaz trial results

By AuntMinnieEurope.com staff writers

A phase III trial found that Lantheus Medical Imaging's flurpiridaz F-18 investigational PET radiopharmaceutical outperformed SPECT myocardial perfusion imaging in patients with suspected coronary artery disease.

September 13, 2022

How widespread is fraud in nuclear medicine research?

By Will Morton

Leading Dutch researchers claim that fraud may be a problem in nuclear medicine journals, based on the results of their global survey. Their findings were published on 8 September in the Journal of Nuclear Medicine.

September 12, 2022

AC Immune receives grant to support a-syn PET tracer development

By AuntMinnieEurope.com staff writers

Swiss biopharmaceutical company AC Immune has received a $500,000 (503,000 euros) grant from the Michael J. Fox Foundation for Parkinson's Research (MJFF) to continue development of its alpha-synuclein (a-syn) PET tracer, ACI-12589.

September 4, 2022

Danish team underlines value of PET tracer for neuroendocrine tumors

By Will Morton

A new gallium-68 PET radiotracer appears to be effective for predicting higher risk of disease progression and mortality in patients with neuroendocrine tumors, according to a study from the University of Copenhagen.

August 28, 2022

United Imaging goes public on Shanghai stock exchange

By AuntMinnieEurope.com staff writers

United Imaging Healthcare on 22 August launched an initial public offering on the Science and Technology Innovation Board of the Shanghai Stock Exchange.

August 22, 2022

AuntMinnieEurope.com Molecular Imaging Insider

By Will Morton

August 16, 2022

4 key clinical areas emerge for optimum use of PET/MRI

By Will Morton

The question today isn't why PET/MRI hybrid scanners should be used over PET/CT but how they can be best put to use. This is the view of a top German specialist in hybrid imaging, who points to four major applications in which PET/MRI is proving to be a game changer.

August 16, 2022

U.K. clears Lu-177 PSMA-617 treatment for prostate cancer

By AuntMinnieEurope.com staff writers

The U.K. regulators have become the first in Europe to clear lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA)-617 treatment for prostate cancer, drug developer Novartis has announced in a news release issued on 11 August.

August 14, 2022

PET/MRI can provide boost for bone infection diagnosis

By Will Morton

A group of orthopedic surgeons in the Netherlands are convinced that medical staff with access to PET/MRI should consider the hybrid modality over other imaging techniques for diagnosing patients with suspected chronic osteomyelitis.

August 11, 2022

PET shows amyloid beta + tau biomarkers = Alzheimer's disease

By Rebekah Moan

Using PET to assess amyloid beta and tau biomarkers, researchers have found in a 30 July JAMA Neurology study that even in individuals without cognitive impairment, these biomarkers are associated with near-term progression to mild cognitive impairment (MCI) and long-term cognitive decline.

August 11, 2022

Which evidence-based indications point to the use of PET/CT?

By Philip Ward

A multidisciplinary team of U.K. experts has produced a comprehensive guide to help determine when the clinical use of PET/CT is justified. The 86-page document can be downloaded free of charge.

August 7, 2022

Previous Page

Page 24 of 121

Next Page